Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease From Oscient Pharmaceuticals Corporation (OSCI) And EPIX Pharmaceuticals, Inc. (EPIX)
12/16/2009 8:53:27 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million
7/14/2009 7:20:20 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) to Cut Sales Force
6/12/2009 7:21:18 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q
5/26/2009 10:31:46 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Reports Fourth Quarter and Full Year 2008 Financial Results
3/25/2009 10:29:55 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Gets Going Concern Notice; Looking at Alternative Including Sale of Company
3/25/2009 8:43:21 AM
More...
|
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation (OSCI) Compliance Period Extended to October 6, 2009
3/24/2009 9:29:41 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Restructures Commercial Organization; Reduces Workforce by 32%
2/12/2009 7:21:02 AM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Extends Maturity of its Privately Placed 5% Convertible Promissory Notes
1/28/2009 10:21:00 AM
More...
|
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation (OSCI) Compliance Period Extended to July 6, 2009
12/23/2008 8:34:19 AM
More...
|
|